Newborn mammalian cardiomyocytes quickly transition from a fetal to an adult phenotype that utilizes mitochondrial oxidative phosphorylation but loses mitotic capacity. We tested whether forced reversal of adult cardiomyocytes back to a fetal glycolytic phenotype would restore proliferative capacity. We deleted Uqcrfs1 (mitochondrial Rieske iron-sulfur protein, RISP) in hearts of adult mice. As RISP protein decreased, heart mitochondrial function declined, and glucose utilization increased. Simultaneously, the hearts underwent hyperplastic remodeling during which cardiomyocyte number doubled without cellular hypertrophy. Cellular energy supply was preserved, AMPK activation was absent, and mTOR activation was evident. In ischemic hearts with RISP deletion, new cardiomyocytes migrated into the infarcted region, suggesting the potential for therapeutic cardiac regeneration. RNA sequencing revealed upregulation of genes associated with cardiac development and proliferation. Metabolomic analysis revealed a decrease in α-ketoglutarate (required for TET-mediated demethylation) and an increase in S-adenosylmethionine (required for methyltransferase activity). Analysis revealed an increase in methylated CpGs near gene transcriptional start sites. Genes that were both differentially expressed and differentially methylated were linked to upregulated cardiac developmental pathways. We conclude that decreased mitochondrial function and increased glucose utilization can restore mitotic capacity in adult cardiomyocytes, resulting in the generation of new heart cells, potentially through the modification of substrates that regulate epigenetic modification of genes required for proliferation.
Gregory B. Waypa, Kimberly A. Smith, Paul T. Mungai, Vincent J. Dudley, Kathryn A. Helmin, Benjamin D. Singer, Clara Bien Peek, Joseph Bass, Lauren Nelson, Sanjiv J. Shah, Gaston Ofman, J. Andrew Wasserstrom, William A. Muller, Alexander V. Misharin, G.R. Scott Budinger, Hiam Abdala-Valencia, Navdeep S. Chandel, Danijela Dokic, Elizabeth Bartom, Shuang Zhang, Yuki Tatekoshi, Amir Mahmoodzadeh, Hossein Ardehali, Edward B. Thorp, Paul T. Schumacker
Title and authors | Publication | Year |
---|---|---|
Molecular gatekeepers of endogenous adult mammalian cardiomyocyte proliferation.
Koopmans T, van Rooij E |
Nature reviews. Cardiology | 2025 |
Mercury-Mediated Cardiovascular Toxicity: Mechanisms and Remedies.
Amin A, Saadatakhtar M, Mohajerian A, Marashi SM, Zamanifard S, Keshavarzian A, Molaee P, Keshmiri MS, Nikdoust F |
Cardiovascular toxicology | 2025 |
The flux of energy in critical illness and the obesity paradox
Jaitovich A, Hall JB |
Physiological reviews | 2025 |
Sulfide regulation and catabolism in health and disease
Hou Y, Lv B, Du J, Ye M, Jin H, Yi Y, Huang Y |
Signal Transduction and Targeted Therapy | 2025 |
Succinate dehydrogenase-complex II regulates skeletal muscle cellular respiration and contractility but not muscle mass in genetically induced pulmonary emphysema.
Balnis J, Tufts A, Jackson EL, Drake LA, Singer DV, Lacomis D, Lee CG, Elias JA, Doles JD, Maher LJ 3rd, Jen A, Coon JJ, Jourd'heuil D, Singer HA, Vincent CE, Jaitovich A |
Science advances | 2024 |
The impact of aging on cardiac repair and regeneration
Anwar I, Wang X, Pratt RE, Dzau VJ, Hodgkinson CP |
The Journal of Biological Chemistry | 2024 |
Functional transformation of macrophage mitochondria in cardiovascular diseases.
Wei J, Peng MY, Lu HX |
Molecular and cellular biochemistry | 2024 |